Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Manor Investment S.A and Ernst Rosén Invest AB in connection with the sale of their respective shares in Rabbalshede Kraft AB
Mandate

Vinge has advised Manor Investment S.A and Ernst Rosén Invest AB in connection with the sale of their respective shares in Rabbalshede Kraft AB

January 20, 2021 M&A

Vinge has advised Manor Investment S.A. and Ernst Rosén AB in connection with the sale of their respective shares in Rabbalshede Kraft AB (publ), in aggregate constituting a majority stake in Rabbalshede Kraft.

Rabbalshede Kraft is a leading and long-term player in renewable energy in the Nordic region. Rabbalshede Kraft plan, build and own land-based wind farms that it sell or manage.

Vinge’s team consisted of, among others, partner Peter Sundgren, associates Isabelle Jengsell and Olivia Belding.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026